Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review
Author:
Funder
ESMO)
Roche
Novartis
Macrogenics
Pfizer
EISAI
AIRC
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference117 articles.
1. Targeting immune checkpoints in non small cell lung cancer;Bianco;Curr Opin Pharmacol,2018
2. An Overview of Immune Checkpoint Inhibitors in Gynecologic Cancers;Castellano;Clin Ther,2018
3. Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies;Marciscano;Curr Treat Options Oncol,2018
4. Current status and perspectives in immunotherapy for metastatic melanoma;Marconcini;Oncotarget,2018
5. PD-1 blockade induces responses by inhibiting adaptive immune resistance;Tumeh;Nature,2014
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Genomic Features of Homologous Recombination Deficiency in Breast Cancer: Impact on Testing and Immunotherapy;Genes;2024-01-26
2. Investigation of Genetic Alterations Associated With Interval Breast Cancer;JAMA Oncology;2024-01-25
3. Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study;Advances in Therapy;2024-01-02
4. DNA repair deficiency and the immune microenvironment: A pathways perspective;DNA Repair;2024-01
5. Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer;The Journal of Gene Medicine;2023-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3